GSK Won UK Cervical Cancer Contract
GlaxoSmithKline has won a contract with the UK’s NHS to supply its cervical cancer vaccine,
Cervarix.
The battle to supply a vaccine against cervical cancer for use across Britain has been won by GlaxoSmithKline (GSK).
Cervarix, the GSK vaccine, will be given to girls aged between 12 and 13, starting in September this year, and should prevent about 70 per cent of cervical cancers — saving 400 lives a year when the effect is fully felt.
Read more from The UK Times Online.
Let’s wait and see what Merck (maker of the other cervical cancer vaccine Gardasil) has to say about this.
Tags: CErvarix, cervical-cancer, cervical-cancer-vaccine, Gardasil, GlaxoSmithKline, Merck, UK NHSRelated Stories
POSTED IN: on anti-cancer ingredients, on cervical cancer
2 opinions for GSK Won UK Cervical Cancer Contract
arthritistreatment
Jul 1, 2008 at 10:34 am
GSK would really win the contract because of its billions of dollars worth of research.
Meaghan Edelstein
Aug 17, 2008 at 12:06 am
I am a Stage 3B Cervical Cancer Survivor. I created a blog in an effort to raise Cervical Cancer Awareness http://www.cancerlost.blogspot.com. I was 28 when I was diagnosed with advanced Cervical Cancer and my story is a long, painful & inspiring one. Cervical Cancer is not talked about but it touches the lives of every single woman out there. We need to start talking about this cancer because it is not rare and it does kill.
http://www.cancerlost.blogspot.com
Have an opinion? Leave a comment: